欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号DK/H/0667/001
药品名称Tififormot
活性成分
    • formoterol fumarate 12.0 µg
剂型Inhalation powder, hard capsule
上市许可持有人Liconsa Gran Via Carlos III, 98, 7 08028 Barcelona Spain
参考成员国 - 产品名称Denmark (DK)
互认成员国 - 产品名称
    • Luxembourg (LU)
许可日期2004/09/01
最近更新日期2008/12/11
药物ATC编码
    • R RESPIRATORY SYSTEM
    • R03 DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES
    • R03A ADRENERGICS, INHALANTS
    • R03AC Selective beta-2-adrenoreceptor agonists
    • R03AC13 formoterol
申请类型
  • TypeLevel1:Abridged
  • TypeLevel2:Multiple (Copy) Application
  • TypeLevel3:Generic Article 4.8(a)(iii), first paragraph
  • TypeLevel4:Chemical Substance
  • TypeLevel5:Prescription Only
附件文件下载
    市场状态Positive
    ©2006-2024 Drugfuture->European Union HMA Authorisation of Medicines DataBase